1. S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS. (23rd June 2022) Authors: Garelius, H.; Smith, A.; Bagguley, T.; Taylor, A.; Fenaux, P.; Bowen, D.; Symeonidis, A.; Mittelmann, M.; Stauder, R.; Čermák, J.; Sanz, G.; Langemeijer, S.; Malcovati, L.; Germing, U.; Itzykson, R.; Guerci-Bresler, A.; Culligan, D.; Kotsianidis, I.; Koinig Mag, K.; van Marrewijk, C. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗